Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab

OBJECTIVE: The aim of this study was to evaluate minimal disease activity (MDA) assessments in patients with PsA during routine clinical care. METHODS: We used data from a multicentre observational study of patients with active PsA who initiated treatment with adalimumab during routine clinical prac...

Descripción completa

Detalles Bibliográficos
Autores principales: Behrens, Frank, Koehm, Michaela, Schwaneck, Eva C, Schmalzing, Marc, Gnann, Holger, Greger, Gerd, Tony, Hans-Peter, Burkhardt, Harald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199539/
https://www.ncbi.nlm.nih.gov/pubmed/30010891
http://dx.doi.org/10.1093/rheumatology/key203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199539/
https://www.ncbi.nlm.nih.gov/pubmed/30010891
http://dx.doi.org/10.1093/rheumatology/key203

Ejemplares similares